QUOTIENT LIMITED 4,444,445 Ordinary Shares (no par value per Share) UNDERWRITING AGREEMENT February 4, 2016Quotient LTD • February 9th, 2016 • In vitro & in vivo diagnostic substances • New York
Company FiledFebruary 9th, 2016 Industry JurisdictionEach of the undersigned, Paul Cowan, Executive Chairman & Chief Executive Officer of Quotient Limited, a company organized under the laws of Jersey (the “Company”), and Stephen Unger, Chief Financial Officer of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(k) of that certain Underwriting Agreement dated [ ] (the “Underwriting Agreement”) among the Company and the Underwriters named therein, that as of [ ]